We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
-9.08%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$23.2B
AUM Growth
-$3.45B
Cap. Flow
-$7.17B
Cap. Flow %
-30.93%
Top 10 Hldgs %
18.24%
Holding
1,260
New
101
Increased
295
Reduced
128
Closed
108
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDX icon
276
FedEx
FDX
$73.5B
$12.5M 0.05%
55,044
-13,337
-20% -$2.85M
ACABU
277
DELISTED
Atlantic Coastal Acquisition Corp. II Unit
ACABU
$12.5M 0.05%
1,250,000
BOCNU
278
DELISTED
Blue Ocean Acquisition Corp Unit
BOCNU
$12.4M 0.05%
1,250,000
K
279
DELISTED
Kellanova
K
$12.4M 0.05%
185,212
+4,987
+3% +$324K
VHNAU
280
DELISTED
Vahanna Tech Edge Acquisition I Corp. Units
VHNAU
$12.4M 0.05%
1,250,000
HCA icon
281
HCA Healthcare
HCA
$86.4B
$12.2M 0.05%
72,678
+1,914
+3% +$411K
DD icon
282
DuPont de Nemours
DD
$18.9B
$12.2M 0.05%
175,019
+4,713
+3% +$386K
NFYS.U
283
DELISTED
Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
NFYS.U
$12.1M 0.05%
1,250,000
ENTFU
284
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Unit
ENTFU
$12M 0.05%
1,200,000
JCI icon
285
Johnson Controls International
JCI
$87.5B
$12M 0.05%
250,661
+6,750
+3% +$376K
HPQ icon
286
HP
HPQ
$24.3B
$11.9M 0.05%
364,348
+9,811
+3% +$360K
WFC.PRL icon
287
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.68B
$11.8M 0.05%
9,717
+481
+5% +$591K
CME icon
288
CME Group
CME
$92.3B
$11.8M 0.05%
57,651
+1,553
+3% +$329K
EOG icon
289
EOG Resources
EOG
$74.7B
$11.8M 0.05%
106,677
+2,873
+3% +$357K
DGX icon
290
Quest Diagnostics
DGX
$25.6B
$11.6M 0.05%
87,219
+2,347
+3% +$320K
JKHY icon
291
Jack Henry & Associates
JKHY
$10.9B
$11.6M 0.05%
64,267
+1,731
+3% +$324K
MRNA icon
292
Moderna
MRNA
$22.1B
$11.5M 0.05%
80,521
+2,169
+3% +$310K
KHC icon
293
Kraft Heinz
KHC
$31.1B
$11.4M 0.05%
299,755
+8,071
+3% +$323K
MTB icon
294
M&T Bank
MTB
$36B
$11.4M 0.05%
71,308
+1,920
+3% +$323K
TEL icon
295
TE Connectivity
TEL
$60.2B
$11.3M 0.05%
100,246
+2,988
+3% +$370K
AVY icon
296
Avery Dennison
AVY
$12.5B
$11.3M 0.05%
69,986
+1,884
+3% +$322K
O icon
297
Realty Income
O
$61.1B
$11.3M 0.05%
165,835
+4,624
+3% +$318K
ADSK icon
298
Autodesk
ADSK
$47.7B
$11.2M 0.05%
65,004
+1,751
+3% +$337K
LULU icon
299
lululemon athletica
LULU
$13.4B
$11.2M 0.05%
40,995
-4,963
-11% -$1.59M
SWK icon
300
Stanley Black & Decker
SWK
$14.6B
$11.1M 0.05%
106,228
+2,861
+3% +$352K

Similar funds

Calamos Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Calamos Advisors held 1,260 positions worth $23.2B, down 13% from $26.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Calamos Advisors withdrew a net $7.17B in Q2 2022, closing 108 positions and reducing 128 holdings. Its most notable exit was Avantor, Inc. Series A Mandatory Convertible Preferred Stock, an estimated $111M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Calamos Advisors opened a new position in Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B worth $32.5M.

  • Calamos Advisors's largest Q2 2022 buy was Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B: 24,529 shares worth $32.5M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $285M increase.
  • Calamos Advisors's biggest Q2 2022 reduction was Bank of America, cutting an estimated $24.1M.
  • Calamos Advisors fully exited Avantor, Inc. Series A Mandatory Convertible Preferred Stock in Q2 2022, selling an estimated $111M.
  • Calamos Advisors's ten largest holdings make up 18% of its $23.2B portfolio in Q2 2022.
  • Calamos Advisors opened 101 new positions and closed 108 in Q2 2022.
  • Calamos Advisors's portfolio value fell 13% quarter-over-quarter to $23.2B.

Based on Calamos Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.